Soft tissue sarcomas of adults: state of the translational science.Ernest C. Borden, Murray F. Brennan, Laurence H. Baker et al.|PubMed|2003Cited by 616
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665Burton Eisenberg, Margaret von Mehren, John M. Kane et al.|Journal of Surgical Oncology|2008Cited by 419
Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132Dian Wang, Burton Eisenberg, Qiang Zhang et al.|Annals of Surgical Oncology|2011Cited by 202
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorMichael C. Heinrich, Jonathan A. Fletcher, Christopher L. Corless et al.|Journal of Clinical Oncology|2023Cited by 145